The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Ovarian Cancer Development and Metastasis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Rubin, M., & Stephen, C. D. (1993) · Cited by 3,149
Danaei, G., Ding, E. L., Mozaffarian, D., Taylor, B., Rehm, J., Murray, C. J. L., & Ezzati, M. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000058 · Cited by 2,860
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Armstrong, D. K., Bundy, B., Wenzel, L., Huang, H. Q., Baergen, R., Lele, S., Copeland, L. J., Walker, J. L., & Burger, R. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052985 · Cited by 2,625
A molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,449
Bristow, R. E., Tomacruz, R. S., Armstrong, D. K., Trimble, E. L., & Montz, F. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.5.1248 · Cited by 2,312
Cannistra, S. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 2,129
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I.-M. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,846
Molecular requirements for epithelial–mesenchymal transition during tumor progression
Huber, M. A., Kraut, N., & Beug, H. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.001 · Cited by 1,821
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
Cavallaro, U., & Christofori, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1276 · Cited by 1,311
McConnell, J. M. L., Shelley, P., Heales, S., John, C., Jensen, R. I., Khan, I. Y., Taylor, P. D., & Poston, L. (2005) · Cited by 1,235
Shih, I.-M., & Kurman, R. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63708-x · Cited by 1,206
PIK3CA is implicated as an oncogene in ovarian cancer
Shayesteh, L., Lu, Y., Kuo, W.-L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G. B., & Gray, J. W. (1999) · Nature Genetics · doi:10.1038/5042 · Cited by 1,155
Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213335.40358.47 · Cited by 1,113
Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma
Singer, G., Oldt, R., Cohen, Y., Wang, B. G., Sidransky, D., Kurman, R. J., & Shih, I.-M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.484 · Cited by 854
Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
Winter, W. E., Maxwell, G. L., Tian, C., Carlson, J. W., Ozols, R. F., Rose, P. G., Markman, M., Armstrong, D. K., Muggia, F., & McGuire, W. P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.2517 · Cited by 845
Comparative lesion sequencing provides insights into tumor evolution
Jones, S., Chen, W.-D., Parmigiani, G., Diehl, F., Beerenwinkel, N., Antal, T., Traulsen, A., Nowak, M. A., Siegel, C., Velculescu, V. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712345105 · Cited by 818
Piek, J. M. J., van Diest, P. J., Zweemer, R. P., Jansen, J. W., Poort‐Keesom, R. J. J., Menko, F. H., Gille, J. J. P., Jongsma, A. P. M., Pals, G., Kenemans, P., et al. (2001) · The Journal of Pathology · doi:10.1002/path.1000 · Cited by 787
Bapat, S. A., Mali, A. M., Koppikar, C. B., & Kurrey, N. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3931 · Cited by 760
Szotek, P. P., Pieretti-Vanmarcke, R., Masiakos, P. T., Dinulescu, D. M., Connolly, D., Foster, R., Dombkowski, D., Preffer, F., MacLaughlin, D. T., & Donahoe, P. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603672103 · Cited by 751
Cheng, J. Q., Godwin, A. K., Bellacosa, A., Taguchi, T., Franke, T. F., Hamilton, T. C., Tsichlis, P. N., & Testa, J. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9267 · Cited by 736
Dinulescu, D. M., Ince, T. A., Quade, B. J., Shafer, S. A., Crowley, D., & Jacks, T. (2005) · Nature Medicine · doi:10.1038/nm1173 · Cited by 604
Garcia, A. A., Hirte, H., Fleming, G., Yang, D., Tsao-Wei, D. D., Roman, L., Groshen, S., Swenson, S., Markland, F., Gandara, D., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.1939 · Cited by 547
Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
Kuo, K.-T., Mao, T.-L., Jones, S., Veras, E., Ayhan, A., Wang, T.-L., Glas, R., Slamon, D., Velculescu, V. E., Kuman, R. J., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.081000 · Cited by 485
Elloul, S., Bukholt Elstrand, M., Nesland, J. M., Tropé, C. G., Kvalheim, G., Goldberg, I., Reich, R., & Davidson, B. (2005) · Cancer · doi:10.1002/cncr.20946 · Cited by 429
Singer, G., Stöhr, R., Cope, L., Dehari, R., Hartmann, A., Cao, D.-F., Wang, T.-L., Kurman, R. J., & Shih, I.-M. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000146025.91953.8d · Cited by 408
Chen, L., Park, S.-M., Tumanov, A. V., Hau, A., Sawada, K., Feig, C., Turner, J. R., Fu, Y.-X., Romero, I. L., Lengyel, E., et al. (2010) · Nature · doi:10.1038/nature09075 · Cited by 378
Self-citationImai, T., Horiuchi, A., Wang, C., Oka, K., Ohira, S., Nikaido, T., & Konishi, I. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63501-8 · Cited by 377
Powell, C. B., Kenley, E., Chen, L.-M., Crawford, B., McLennan, J., Zaloudek, C., Komaromy, M., Beattie, M., & Ziegler, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.109 · Cited by 372
Kenny, H. A., Kaur, S., Coussens, L. M., & Lengyel, E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33775 · Cited by 370
Self-citationThe cell of origin of ovarian epithelial tumours
Dubeau, L. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70308-5 · Cited by 363
Huang, S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.15.1134 · Cited by 349
Byrne, A. T., Ross, L. H., Holash, J., Nakanishi, M., Hu, L., Hofmann, J., Yancopoulos, G. D., & Jaffe, R. B. (2003) · PubMed · Cited by 310
Marquez, R. T., Baggerly, K. A., Patterson, A. P., Liu, J., Broaddus, R., Frumovitz, M., Atkinson, E. N., Smith, D. I., Hartmann, L., Fishman, D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2509 · Cited by 308
Cheng, W., Liu, J., Yoshida, H., Rosen, D., & Naora, H. (2005) · Nature Medicine · doi:10.1038/nm1230 · Cited by 305
Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts.
Tarin, D., Price, J. E., Kettlewell, M. G. W., Souter, R. G., Ac, V., & Crossley, B. (1984) · PubMed · Cited by 303
Clinical Behavior of Stage II-IV Low-Grade Serous Carcinoma of the Ovary
Gershenson, D. M., Sun, C. C., Lu, K. H., Coleman, R. L., Sood, A. K., Malpica, A., Deavers, M. T., Silva, E. G., & Bodurka, D. C. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000227787.24587.d1 · Cited by 290
Flesken‐Nikitin, A., Choi, K., Eng, J. P., Shmidt, E. N., & Nikitin, A. Y. (2003) · PubMed · Cited by 271
Burleson, K. M., Casey, R. C., Skubitz, K. M., Pambuccian, S. E., Oegema, T. R., & Skubitz, A. P. N. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.12.034 · Cited by 269
Sawada, K., Radjabi, A. R., Shinomiya, N., Kistner, E., Kenny, H., Becker, A. R., Turkyilmaz, M. A., Salgia, R., Yamada, S. D., Vande Woude, G. F., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1147 · Cited by 258
Self-citationDifferential Gene Expression in Ovarian Carcinoma
Hibbs, K., Skubitz, K. M., Pambuccian, S. E., Casey, R. C., Burleson, K. M., Oegema, T. R., Thiele, J. J., Grindle, S. M., Bliss, R. L., & Skubitz, A. P. N. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63306-8 · Cited by 256
The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection
Brown, P. O., & Palmer, C. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000114 · Cited by 246
Kenny, H. A., Krausz, T., Yamada, S. D., & Lengyel, E. (2007) · International Journal of Cancer · doi:10.1002/ijc.22874 · Cited by 243
Ahmed, N., Thompson, E. W., & Quinn, M. A. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21240 · Cited by 237
Symowicz, J., Adley, B. P., Gleason, K. J., Johnson, J. J., Ghosh, S., Fishman, D. A., Hudson, L. G., & Stack, M. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2808 · Cited by 235
β1-Integrins Regulate the Formation and Adhesion of Ovarian Carcinoma Multicellular Spheroids
Casey, R. C., Burleson, K. M., Skubitz, K. M., Pambuccian, S. E., Oegema, T. R., Ruff, L. E., & Skubitz, A. P. N. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63058-1 · Cited by 225
Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.
Cannistra, S., Kansas, G. S., Niloff, J. M., DeFranzo, B., Kim, Y. S., & Ottensmeier, C. H. H. (1993) · PubMed · Cited by 211
Kurman, R. J., Visvanathan, K., Roden, R., Wu, T. C., & Shih, I.-M. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.01.005 · Cited by 203
Why did p53 gene therapy fail in ovarian cancer?
Zeimet, A. G., & Marth, C. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01139-2 · Cited by 199
Kuo, K.-T., Guan, B., Feng, Y., Mao, T.-L., Chen, X., Jinawath, N., Wang, Y., Kurman, R. J., Shih, I.-M., & Wang, T.-L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3913 · Cited by 196
Predicting biomarkers for ovarian cancer using gene-expression microarrays
Adib, T. R., Henderson, S., Perrett, C., Hewitt, D., Bourmpoulia, D., Ledermann, J., & Boshoff, C. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601603 · Cited by 193
Hudson, L. G., Zeineldin, R., & Stack, M. S. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9171-5 · Cited by 186
Spectrum of Mutation and Frequency of Allelic Deletion of the p53 Gene in Ovarian Cancer
Kohler, M. F., Marks, J. R., Wiseman, R. W., Jacobs, I. J., Davidoff, A. M., Clarke-Pearson, D. L., Soper, J. T., Bast, R. C., & Berchuck, A. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.18.1513 · Cited by 184
p53 mutation is a common genetic event in ovarian carcinoma.
Milner, B. J., Allan, L. A., Eccles, D., Kitchener, H. C., Léonard, R., Kelly, K. F., Parkin, D. E., & Haites, N. E. (1993) · PubMed · Cited by 175
β1-Integrins Partly Mediate Binding of Ovarian Cancer Cells to Peritoneal Mesothelium in Vitro
Strobel, T., & Cannistra, S. A. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5388 · Cited by 168
Frankel, A., Buckman, R. A., & Kerbel, R. S. (1997) · PubMed · Cited by 166
Molecular genetic evidence that endometriosis is a precursor of ovarian cancer
Prowse, A. H., Manek, S., Varma, R., Liu, J., Godwin, A. K., Maher, E. R., Tomlinson, I. P. M., & Kennedy, S. H. (2006) · International Journal of Cancer · doi:10.1002/ijc.21845 · Cited by 164
MMP-2 functions as an early response protein in ovarian cancer metastasis
Kenny, H. A., & Lengyel, E. R. (2009) · Cell Cycle · doi:10.4161/cc.8.5.7703 · Cited by 155
Self-citationFunctional significance of VEGFR‐2 on ovarian cancer cells
Spannuth, W. A., Nick, A. M., Jennings, N. B., Armaiz-Peña, G. N., Mangala, L. S., Danes, C. G., Lin, Y. G., Merritt, W. M., Thaker, P. H., Kamat, A. A., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.24028 · Cited by 153
Burleson, K. M., Hansen, L. K., & Skubitz, A. P. N. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-004-5768-5 · Cited by 150
Daraï, É., Scoazec, J., Walker, F., Mlika-Cabanne, N., Feldmann, G., Madélénat, P., & Potet, F. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90007-1 · Cited by 146
Shao, M., Cao, L., Shen, C., Satpathy, M., Chelladurai, B. S., Bigsby, R. M., Nakshatri, H., & Matei, D. E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1257 · Cited by 139
Tumors of the breast and female genital organs
Chu, P. G., & Weiss, L. M. (2000) · Cambridge University Press eBooks · doi:10.1017/cbo9781316167366.008 · Cited by 136
Veatch, A. L., Carson, L. F., & Ramakrishnan, S. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580315 · Cited by 134
Characterization of Active Mitogen-Activated Protein Kinase in Ovarian Serous Carcinomas
Hsu, C., Bristow, R. E., Cha, M. S., Wang, B. G., Ho, C., Kurman, R. J., Wang, T., & Shih, I. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0893 · Cited by 132
Cadherin switching in ovarian cancer progression
Patel, I. S., Madan, P., Getsios, S., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11086 · Cited by 131
Sehouli, J., Senyuva, F., Fotopoulou, C., Neumann, U. P., Denkert, C., Lichtenegger, W., & Gülten, O. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21288 · Cited by 129
Hu, L., Hofmann, J., Holash, J. A., Yancopoulos, G. D., Sood, A. K., & Jaffe, R. B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0910 · Cited by 127
Expression and Function of β1 and αvβ3 Integrins in Ovarian Cancer
Cannistra, S. A., Ottensmeier, C. H. H., Niloff, J. M., Orta, B., & DiCarlo, J. (1995) · Gynecologic Oncology · doi:10.1006/gyno.1995.1214 · Cited by 126
Ströbel, T., Swanson, L., & Cannistra, S. A. (1997) · PubMed · Cited by 123
Enhanced Peritoneal Ovarian Tumor Dissemination by Tissue Transglutaminase
Satpathy, M., Cao, L., Pincheira, R., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0307 · Cited by 123
Expression and function of β1 and αvβ3 integrins in ovarian cancer
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)84550-4 · Cited by 120
Shield, K., Riley, C. B., Quinn, M. A., Rice, G. E., Ackland, M. L., & Ahmed, N. (2007) · Journal of Carcinogenesis · doi:10.1186/1477-3163-6-11 · Cited by 119
Precursors to pelvic serous carcinoma and their clinical implications
Folkins, A. K., Jarboe, E. A., Roh, M. H., & Crum, C. P. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.01.013 · Cited by 116
Moser, T. L., Pizzo, S. V., Bafetti, L. M., Fishman, D. A., & Stack, M. S. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960904)67:5<695::aid-ijc18>3.0.co;2-4 · Cited by 113
FACTORS IN THE CAUSATION AND INCIDENCE OF OVARIAN CANCER
Fathalla, M. F. (1972) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-197211000-00001 · Cited by 112
Moss, N. M., Barbolina, M. V., Liu, Y., Sun, L., Munshi, H. G., & Stack, M. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4151 · Cited by 110
Green, S. K., Francia, G., Isidoro, C., & Kerbel, R. S. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.149.3.2 · Cited by 107
Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma
Hwang, J. Y., Mangala, L. S., Fok, J. Y., Lin, Y. G., Merritt, W. M., Spannuth, W. A., Nick, A. M., Fiterman, D. J., Vivas‐Mejía, P. E., Deavers, M. T., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6130 · Cited by 106
Kenny, H. A., Dogan, S., Zillhardt, M., Mitra, A. K., Yamada, S. D., Krausz, T. N., & Lengyel, E. R. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-98094-2_16 · Cited by 96
Self-citationComposition of the extracellular matrix of the peritoneum
Witz, C. (2001) · Journal of the Society for Gynecologic Investigation · doi:10.1016/s1071-5576(01)00122-8 · Cited by 96
Haverty, P. M., Hon, L., Kaminker, J. S., Chant, J., & Zhang, Z. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-21 · Cited by 96
Eisenkop, S. M., & Spirtos, N. M. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6232 · Cited by 94
Autocrine VEGF‐A/KDR loop protects epithelial ovarian carcinoma cells from anoikis
Sher, I., Adham, S. A., Petrik, J., & Coomber, B. L. (2008) · International Journal of Cancer · doi:10.1002/ijc.23963 · Cited by 90
The origin of ovarian carcinomas: A developmental view
Auersperg, N., Woo, M. M. M., & Gilks, C. B. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.05.031 · Cited by 81
Heath, R. M., Jayne, D. G., O’Leary, R., Morrison, E. E., & Guillou, P. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601635 · Cited by 74
Kaur, S., Kenny, H. A., Jagadeeswaran, S., Zillhardt, M., MONTAG, A. G., Kistner, E. O., Yamada, S. D., Mitra, A. K., & Lengyel, E. R. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090028 · Cited by 72
Self-citationSatpathy, M., Shao, M., Emerson, R. E., Donner, D. B., & Matei, D. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808331200 · Cited by 69
The clonal evolution of metastases from primary serous epithelial ovarian cancers
Khalique, L., Ayhan, A., Whittaker, J. C., Singh, N., Jacobs, I. J., Gayther, S. A., & Ramus, S. J. (2008) · International Journal of Cancer · doi:10.1002/ijc.24148 · Cited by 68
Davidson, B., Goldberg, I., Berner, A., Nesland, J. M., Givant-Horwitz, V., Bryne, M., Risberg, B. Å., Kristensen, G. B., Tropé, C. G., Kopolovic, J., et al. (2001) · American Journal of Clinical Pathology · doi:10.1309/b1yx-l8db-tgy1-7905 · Cited by 64
Pathology of the peritoneum: a review of selected topics.
Daya, D., & McCaughey, W. (1991) · PubMed · Cited by 59
Banz, C., Ungethuem, U., Kuban, R.-J., Diedrich, K., Lengyel, E. R., & Hornung, D. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.06.039 · Cited by 53
Self-citationDevelopmental Patterning in the Wrong Context: The Paradox of Epithelial Ovarian Cancers
Naora, H. (2005) · Cell Cycle · doi:10.4161/cc.4.8.1906 · Cited by 35
Loessner, D., Abou‐Ajram, C., Benge, A., et al. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.05.014 · Cited by 30
A new model of ovarian carcinogenesis may influence early detection strategies
Burger, R. A. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.01.004 · Cited by 8
Cited by
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279
Self-citationWhole–genome characterization of chemoresistant ovarian cancer
Patch, A.-M., Christie, E. L., Etemadmoghadam, D., Garsed, D. W., George, J., Fereday, S., Nones, K., Cowin, P., Alsop, K., Bailey, P. J., et al. (2015) · Nature · doi:10.1038/nature14410 · Cited by 1,569
Self-citationMechanisms of disseminated cancer cell dormancy: an awakening field
Sosa, M. S., Bragado, P., & Aguirre-Ghiso, J. A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3793 · Cited by 1,126
Adipose tissue and adipocytes support tumorigenesis and metastasis
Nieman, K. M., Romero, I. L., Van Houten, B., & Lengyel, E. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.02.010 · Cited by 749
Self-citationHigh-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
Lisio, M.-A., Fu, L., Goyeneche, A., Gao, Z.-H., & Telleria, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040952 · Cited by 680
Metadata
- Authors
- Lengyel, E.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 177
- Issue
- 3
- Pages
- 1053-1064
- ISSN
- 0002-9440 (ISSN-L)
- OpenAlex
- W2042633087
- Cited by
- 1,672
- References
- 98
- FWCI
- 36.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.